SUBSCRIBE
SUBSCRIBE

Adial Pharmaceuticals

NEWS
Business
BioSpace Movers & Shakers: Tessera, Tessa, Adial and More
This week’s Movers & Shakers includes Tessa and Adial bringing in new CEOs, while other companies strengthened their regulatory and medical teams with key appointments
August 25, 2022
 · 
6 min read
 · 
Alex Keown
Lindsay Moore-Fields, Center for Healthcare Innova
Business
Beyond Increments: Black Perspectives on Representation in the Life Sciences
BioSpace spoke with several Black individuals working within the life sciences to get their thoughts on the current representative disconnect and what they believe can be done to fix it.
June 28, 2022
 · 
10 min read
 · 
Heather McKenzie
Alcohol use disorder is risky which should be cont
Drug Development
Adial is Leveraging Genomics to Treat “Pervasive” Alcohol Use Disorder
Alcohol use disorder is common among the population for a very long time. Adial is planning to leverage genomics that can treat pervasive alcohol use disorder.
April 4, 2022
 · 
6 min read
 · 
Abbey Glasure
IN THE PRESS
Press Releases
Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
July 10, 2025
 · 
4 min read
Press Releases
Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply
June 25, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
June 18, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting
June 16, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
June 11, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
 · 
9 min read
Press Releases
Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study
May 14, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration
May 8, 2025
 · 
4 min read
Press Releases
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds
May 2, 2025
 · 
6 min read
Press Releases
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
May 1, 2025
 · 
5 min read
Load More
JOBS